Federica Blua

Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage

Elisabetta Marini, B. Rolando, L. Lazzarato, 2023, Antioxidants.

Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein

F. Spyrakis, Elisabetta Marini, B. Rolando, 2022, Molecules.

Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor

F. Spyrakis, Elisabetta Marini, M. Bertinaria, 2021, Molecules.

Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation.

F. Spyrakis, Elisabetta Marini, B. Rolando, 2023, European journal of medicinal chemistry.